Arbor Biotechnologies Competitors and Similar CompaniesClear all
Arbor Biotechnologies's competitors and similar companies include Editas Medicine, Sana Biotechnology, Nuclera and Caribou Biosciences.
 Arbor Biotechnologies Arbor Biotechnologies is a company that provides genetic medicines through the discovery of programmable DNA editors. |  Editas Medicine Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics. |  Caribou Biosciences Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company. | |||
Founding Date | Founding Date 2016 | Founding Date 2013 | Founding Date 2018 | Founding Date 2013 | Founding Date 2012 |
Type | Type Private | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Cambridge, US HQ | Locations Cambridge, US HQ Boulder, US Cambridge, US | Locations Seattle, US HQ Cambridge, US South San Francisco, US | Locations Cambridge, GB HQ | Locations Berkeley, US HQ |
Employees | Employees 1141% increase | Employees 20816% increase | Employees 19441% decrease | Employees 1192% decrease | Employees 1477% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 256.5 m | Valuation ($) 840.9 m | Valuation ($) N/A | Valuation ($) 174.4 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $40.5m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $11.2m (FY, 2025) |
Net income | Net income N/A | Net income ($160.1m) (FY, 2025) | Net income ($244.2m) (FY, 2025) | Net income N/A | Net income ($148.1m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 215m (over 4 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 10m (over 7 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 215m | Total funding raised $ 210m | Total funding raised $ 700m | Total funding raised $ 11.3m | Total funding raised $ 159.5m |
For sources of this data, please see the company profile
View Company Profiles
Editas Medicine
HQ
Cambridge, US
Employees
208↑ 16% increase
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
View company
Sana Biotechnology
HQ
Seattle, US
Employees
194↓ 41% decrease
Sana Biotechnology is a company specializing in cell and gene therapy.
View company
Nuclera
HQ
Cambridge, GB
Employees
119↓ 2% decrease
Nuclera is a company that specializes in DNA synthesis.
View companyCaribou Biosciences
HQ
Berkeley, US
Employees
147↓ 7% decrease
Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company.
View company